Faricimab Antibody is a research-grade biosimilar monoclonal antibody targeting Vascular endothelial growth factor A. It is a humanized IgG1-kappa-lambda antibody. Reactivity: Human. Supplied as a liquid in 20 mM His, 140mM NaCl, pH6.0. Applications: ELISA, flow cytometry, functional assays and in vivo research. Endotoxin: < 10 EU/mg. Purity: >95% purity as determined by SDS-PAGE. For research use only.
Zifibancimig is an anti-VEGFA/ANGPT2 IgG1κ monoclonal antibody.
Product Name:
Faricimab Antibody
SKU:
GXBS00420
Size:
100 µg, 1 mg
Antibody Type:
Monoclonal Antibody
Target:
Vascular endothelial growth factor A
Isotype:
IgG1-kappa-lambda
Host Species:
Human
Reactivity:
Human
Applications:
ELISA, FACS, Functional assay, Research in vivo
Expression Host:
Mammalian cells
Synonyms:
Bispecific, RG7716, RO6867461, 1607793-29-2
Purity:
>95% purity as determined by SDS-PAGE.
Endotoxin Level:
< 10 EU/mg
Formulation:
20 mM His, 140mM NaCl, pH6.0
State of Matter:
Liquid
Regulatory Status:
For research use only. Not suitable for clinical or therapeutic use.
Product Preparation:
Protein A/G purified from cell culture supernatant.
Storage and Handling:
Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
